NCT07001956View on ClinicalTrials.gov

The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 30, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2040

Conditions
Rheumatoid Arthritis (RA)
Interventions
BIOLOGICAL

UTAA91 injection

After signing the informed consent form, eligible subjects will receive an infusion of UTAA91 injection. Blood samples will be collected from the subjects before and after the infusion for the evaluation of pharmacokinetics, pharmacodynamics, immunogenicity, and safety.

Trial Locations (1)

430000

RECRUITING

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER